Blood N-terminal pro-brain natriuretic peptide and interleukin-17 for distinguishing incomplete Kawasaki disease from infectious diseases

作者: Ling Wu , Yuanling Chen , Shiling Zhong , Yunyan Li , Xiahua Dai

DOI: 10.1007/S13312-015-0659-1

关键词: VasculitisMedicineNatriuretic peptideKawasaki diseaseImmunologyBiomarker (medicine)Maternal and child healthInterleukin 17N-terminal pro-Brain Natriuretic Peptide

摘要: Objective To explore the diagnostic value of blood N-terminal pro-brain natriuretic peptide (NT-proBNP) and interleukin-17(IL- 17) for incomplete Kawasaki disease.

参考文章(13)
Mohan S. Maddur, Pierre Miossec, Srini V. Kaveri, Jagadeesh Bayry, Th17 Cells: Biology, Pathogenesis of Autoimmune and Inflammatory Diseases, and Therapeutic Strategies American Journal of Pathology. ,vol. 181, pp. 8- 18 ,(2012) , 10.1016/J.AJPATH.2012.03.044
S. Jia, C. Li, G. Wang, J. Yang, Y. Zu, The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease Clinical and Experimental Immunology. ,vol. 162, pp. 131- 137 ,(2010) , 10.1111/J.1365-2249.2010.04236.X
Olaf Penack, Thomas Beinert, Dieter Buchheidt, Hermann Einsele, Holger Hebart, Michael G. Kiehl, Gero Massenkeil, Xaver Schiel, Jan Schleicher, Philipp B. Staber, Stefan Wilhelm, Hans Wolf, Helmut Ostermann, Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO) Annals of Hematology. ,vol. 85, pp. 424- 433 ,(2006) , 10.1007/S00277-006-0096-2
Pierre Miossec, Jay K. Kolls, Targeting IL-17 and TH17 cells in chronic inflammation. Nature Reviews Drug Discovery. ,vol. 11, pp. 763- 776 ,(2012) , 10.1038/NRD3794
Farhad Jadidi-Niaragh, Abbas Mirshafiey, The deviated balance between regulatory T cell and Th17 in autoimmunity. Immunopharmacology and Immunotoxicology. ,vol. 34, pp. 727- 739 ,(2012) , 10.3109/08923973.2011.619987
Daisuke Sudo, Yoshiro Monobe, Mayumi Yashiro, Makiko Naka Mieno, Ritei Uehara, Keiji Tsuchiya, Tomoyoshi Sonobe, Yosikazu Nakamura, Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan European Journal of Pediatrics. ,vol. 171, pp. 651- 656 ,(2012) , 10.1007/S00431-011-1630-3
H. Muta, M. Ishii, M. Yashiro, R. Uehara, Y. Nakamura, Late Intravenous Immunoglobulin Treatment in Patients With Kawasaki Disease Pediatrics. ,vol. 129, ,(2012) , 10.1542/PEDS.2011-1704
Satoru Iwashima, Takamichi Ishikawa, B-type natriuretic peptide and N-terminal pro-BNP in the acute phase of Kawasaki disease World Journal of Pediatrics. ,vol. 9, pp. 239- 244 ,(2013) , 10.1007/S12519-013-0402-8
Jane W Newburger, Masato Takahashi, Michael A Gerber, Michael H Gewitz, Lloyd Y Tani, Jane C Burns, Stanford T Shulman, Ann F Bolger, Patricia Ferrieri, Robert S Baltimore, Walter R Wilson, Larry M Baddour, Matthew E Levison, Thomas J Pallasch, Donald A Falace, Kathryn A Taubert, None, Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association Pediatrics. ,vol. 114, pp. 1708- 1733 ,(2004) , 10.1542/PEDS.2004-2182
E. Omoyinmi, R. Hamaoui, A. Pesenacker, K. Nistala, H. Moncrieffe, S. Ursu, L. R. Wedderburn, P. Woo, Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis Rheumatology. ,vol. 51, pp. 1881- 1886 ,(2012) , 10.1093/RHEUMATOLOGY/KES162